Company / Income Tax
Haemonetics Income Tax History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$44.4M
FY2024
5-year range
$20.3M / $44.4M
FY2020-FY2024
Trend
+29.4%
vs FY2023
Sector context
#65 of 156
Health Care
What the data says
At $44M, Haemonetics's income tax ranks #92 of 156 in the Health Care sector. Income Tax has increased for 4 consecutive years, from -$7M in FY2020 to $44M in FY2024.
Based on SEC 10-K filings.
$44M in FY2024 with a 5-year CAGR of +33.1%.
Increased from $26M to $44M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +29.9%
- 5-Year CAGR
- +33.1%
- 10-Year CAGR
- -
Sector benchmark
#92 of 156 in Health CareTop 58% of 156This company $44.4M Sector average $142.5M
▼
-68.8% below sector average
Key checks
Key Insights
- Haemonetics's income tax has grown for 4 consecutive years.
- 5-year CAGR of +33.1%, indicating consistent growth.
- In FY2024, income tax increased 29.4% year-over-year.
- Ranks #65 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $44.4M | +29.4% |
| FY2023 | $34.3M | +31.9% |
| FY2022 | $26.0M | +28.4% |
| FY2021 | $20.3M | +408.9% |
| FY2020 | -$6.6M | -161.7% |
| FY2019 | $10.6M | -42.9% |
| FY2018 | $18.6M | +32.4% |
| FY2017 | $14.1M | +1263.9% |
| FY2016 | -$1.2M | -155.8% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026